These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28320438)

  • 1. Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.
    Maddur MS; Stephen-Victor E; Das M; Prakhar P; Sharma VK; Singh V; Rabin M; Trinath J; Balaji KN; Bolgert F; Vallat JM; Magy L; Kaveri SV; Bayry J
    J Neuroinflammation; 2017 Mar; 14(1):58. PubMed ID: 28320438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.
    Maddur MS; Rabin M; Hegde P; Bolgert F; Guy M; Vallat JM; Magy L; Bayry J; Kaveri SV
    Immunol Res; 2014 Dec; 60(2-3):320-9. PubMed ID: 25391612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin promotes the proliferation of CD4
    Zhang G; Wang Q; Song Y; Cheng P; Xu R; Feng X; Li X
    J Neuroimmunol; 2019 Nov; 336():577042. PubMed ID: 31479869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IVIg-induced plasmablasts in patients with Guillain-Barré syndrome.
    Brem MD; Jacobs BC; van Rijs W; Fokkink WJR; Tio-Gillen AP; Walgaard C; van Doorn PA; IJspeert H; van der Burg M; Huizinga R
    Ann Clin Transl Neurol; 2019 Jan; 6(1):129-143. PubMed ID: 30656191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialylated intravenous immunoglobulin suppress anti-ganglioside antibody mediated nerve injury.
    Zhang G; Massaad CA; Gao T; Pillai L; Bogdanova N; Ghauri S; Sheikh KA
    Exp Neurol; 2016 Aug; 282():49-55. PubMed ID: 27208700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
    Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
    Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
    Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
    J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.
    Fokkink WR; Walgaard C; Kuitwaard K; Tio-Gillen AP; van Doorn PA; Jacobs BC
    JAMA Neurol; 2017 Feb; 74(2):189-196. PubMed ID: 28027337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome.
    Chi LJ; Wang HB; Zhang Y; Wang WZ
    J Neuroimmunol; 2007 Dec; 192(1-2):206-14. PubMed ID: 17997492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent plasmacytosis following intravenous immunoglobulin correlates with clinical improvement in Guillain-Barré syndrome.
    Mori I; Parizot C; Dorgham K; Demeret S; Amoura Z; Bolgert F; Gorochov G
    PLoS One; 2008 May; 3(5):e2109. PubMed ID: 18461177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumour necrosis factor alpha & soluble TNF receptors in patients with Guillain-Barre syndrome.
    Radhakrishnan VV; Sumi MG; Reuben S; Mathai A; Nair MD
    Indian J Med Res; 2003 May; 117():216-20. PubMed ID: 14609050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells.
    Trinath J; Hegde P; Sharma M; Maddur MS; Rabin M; Vallat JM; Magy L; Balaji KN; Kaveri SV; Bayry J
    Blood; 2013 Aug; 122(8):1419-27. PubMed ID: 23847198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin attenuates experimental autoimmune arthritis by inducing reciprocal regulation of Th17 and Treg cells in an interleukin-10-dependent manner.
    Lee SY; Jung YO; Ryu JG; Kang CM; Kim EK; Son HJ; Yang EJ; Ju JH; Kang YS; Park SH; Kim HY; Cho ML
    Arthritis Rheumatol; 2014 Jul; 66(7):1768-78. PubMed ID: 24644005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment.
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Dolati S; Farzadi L; Ghasemzadeh A; Hamdi K; Younesi V; Nouri M; Yousefi M
    Syst Biol Reprod Med; 2017 Dec; 63(6):350-359. PubMed ID: 29099629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin reduces serum tumor necrosis factor alpha in patients with Guillain-Barre syndrome.
    Reuben S; Sumi MG; Mathai A; Nair MD; Radhakrishnan VV
    Neurol India; 2003 Dec; 51(4):487-9. PubMed ID: 14742928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain-Barré syndrome.
    Li C; Luo T; Cheng Y; Liu S; Qiao L; Wu X; Liu K
    Neurol Sci; 2020 Feb; 41(2):295-303. PubMed ID: 31494821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
    Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
    Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
    Verboon C; van den Berg B; Cornblath DR; Venema E; Gorson KC; Lunn MP; Lingsma H; Van den Bergh P; Harbo T; Bateman K; Pereon Y; Sindrup SH; Kusunoki S; Miller J; Islam Z; Hartung HP; Chavada G; Jacobs BC; Hughes RAC; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum tumour necrosis factor-alpha and soluble tumour necrosis factor receptors levels in patients with Guillain-Barre syndrome.
    Radhakrishnan VV; Sumi MG; Reuben S; Mathai A; Nair MD
    Acta Neurol Scand; 2004 Jan; 109(1):71-4. PubMed ID: 14653854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.
    Li S; Jin T; Zhang HL; Yu H; Meng F; Concha Quezada H; Zhu J
    Mediators Inflamm; 2014; 2014():740947. PubMed ID: 24899787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.